|
|
Volumn 11, Issue 5, 2012, Pages 339-340
|
|
Oncology trials gear up for high-throughput sequencing
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER GENETICS;
CLINICAL TRIAL (TOPIC);
DRUG RESEARCH;
FINANCIAL MANAGEMENT;
GENE EXPRESSION PROFILING;
GENE MUTATION;
GENE SEQUENCE;
GENE TECHNOLOGY;
GENETIC ANALYSIS;
GENETIC HETEROGENEITY;
GENETIC VARIABILITY;
HIGH THROUGHPUT SEQUENCING;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
MICROARRAY ANALYSIS;
PATIENT PARTICIPATION;
PATIENT SELECTION;
PERSONALIZED MEDICINE;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
SHORT SURVEY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG DESIGN;
GENOMICS;
HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING;
HUMANS;
INDIVIDUALIZED MEDICINE;
MEDICAL ONCOLOGY;
NEOPLASMS;
|
|
EID: 84860365180
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3733 Document Type: Short Survey |
|
Times cited : (4)
|
|
References (0)
|
